Cited by 467Chronic Kidney Disease and DiabetesAcute Kidney Injury ResearchDiabetes Treatment and Management

The DOI matches its Crossref record; 210 of the 211 references it cites were found in a registry or an index.

The tubular hypothesis of nephron filtration and diabetic kidney disease

Open access

Vallon, Volker, Thomson, Scott C.·2020·Nature Reviews Nephrology

DOI 10.1038/s41581-020-0256-yPMC PMC7242158

Open this paper in CoChat — free account

Abstract

Kidney size and glomerular filtration rate (GFR) often increase with the onset of diabetes, and elevated GFR is a risk factor for the development of diabetic kidney disease. Hyperfiltration mainly occurs in response to signals passed from the tubule to the glomerulus: high levels of glucose in the glomerular filtrate drive increased reabsorption of glucose and sodium by the sodium-glucose cotransporters SGLT2 and SGLT1 in the proximal tubule. Passive reabsorption of chloride and water also increases. The overall capacity for proximal reabsorption is augmented by growth of the proximal tubule, which (alongside sodium-glucose cotransport) further limits urinary glucose loss. Hyperreabsorption of sodium and chloride induces tubuloglomerular feedback from the macula densa to increase GFR. In addition, sodium-glucose cotransport by SGLT1 on macula densa cells triggers the production of nitric oxide, which also contributes to glomerular hyperfiltration. Although hyperfiltration restores sodium and chloride excretion it imposes added physical stress on the filtration barrier and increases the oxygen demand to drive reabsorption. Tubular growth is associated with the development of a senescence-like molecular signature that sets the stage for inflammation and fibrosis. SGLT2 inhibitors attenuate the proximal reabsorption of sodium and glucose, normalize tubuloglomerular feedback signals and mitigate hyperfiltration. This tubule-centred model of diabetic kidney physiology predicts the salutary effect of SGLT2 inhibitors on hard renal outcomes, as shown in large-scale clinical trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41581-020-0256-y

Cites

210 of 210 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Zelniker, T. A., Wiviott, S. D., Raz, I., Im, K., Goodrich, E. L., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Furtado, R. H. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32590-x · Cited by 2,845
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B. M., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J. Z., Balkrishnan, R., Bragg‐Gresham, J. L., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,192
Biology of Human Sodium Glucose Transporters
Wright, E. M., Loo, D. D. F., & Hirayama, B. A. (2011) · Physiological Reviews · doi:10.1152/physrev.00055.2009 · Cited by 1,430
Diabetic kidney disease
Thomas, M. C., Brownlee, M., Suszták, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P. R., Groop, P., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,335

Show all 211 references

Research works printed but not linked: 1

Fu, Y., Gerasimova, M., Mayoux, E., Masuda, T. & Vallon, V. SGLT2 inhibitor empagliflozin increases renal NHE3 phosphorylation in diabetic Akita mice: possible implications for the prevention of glomerular hyperfiltration. Diabetes 63, (supplement 1), A132 (2014).

Sorted by citations

Items 101–200 of 467

Diuretic resistance in patients with kidney disease: Challenges and opportunities
Guo, L., Fu, B., Liu, Y., Hao, N., Ji, Y., & Yang, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114058 · Cited by 33
Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis
Li, N., Zhou, G., Zheng, Y., Lv, D., Zhu, X., Wei, P., Zheng, M., Liu, S., Zhou, E., Sun, W., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261986 · Cited by 30
Childhood Obesity: Insight into Kidney Involvement
Carullo, N., Zicarelli, M., Michael, A., Faga, T., Battaglia, Y., Pisani, A., Perticone, M., Costa, D., Ielapi, N., Coppolino, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417400 · Cited by 33
Tubular effects of sodium–glucose cotransporter 2 inhibitors: intended and unintended consequences
Rieg, J. A. D., Xue, J., & Rieg, T. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000632 · Cited by 32
Renal Tubular Handling of Glucose and Fructose in Health and Disease
Vallon, V., & Nakagawa, T. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210030 · Cited by 49
Self-citation
Senescent renal tubular epithelial cells activate fibroblasts by secreting Shh to promote the progression of diabetic kidney disease
Wang, D., Yin, L., Chen, R., Tan, W., Liang, L., Xiang, J., Zhang, H., Zhou, X., Deng, H., Guo, B., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1018298 · Cited by 28
Suppression of ferroptosis through the SLC7A11/glutathione/glutathione peroxidase 4 axis contributes to the therapeutic action of the Tangshenning formula on diabetic renal tubular injury
Shan, X., Chen, C.-W., Zou, D.-W., Gao, Y., Ba, Y., He, J., Zhu, Z., & Liang, J. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01007-8 · Cited by 28
Empagliflozin protects the kidney by reducing toxic ALB (albumin) exposure and preventing autophagic stagnation in proximal tubules
Matsui, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba‐Hamano, T., Matsuda, J., Minami, S., Sakai, S., Yonishi, H., Nakamura, J., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2410621 · Cited by 27
The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
Oe, Y., & Vallon, V. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2020032 · Cited by 29
Self-citation
Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis
Zhao, Z., Yan, Q., Li, F., Li, G., Liu, Y., Li, J., Pan, S., Zhou, S., Duan, J., Liu, D., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107480 · Cited by 27
YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis
Yang, T., Hu, Y., Chen, S., Li, L., Cao, X., Yuan, J., Shu, F., Jiang, Z., Qian, S., Zhu, X., et al. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09711-7 · Cited by 26
Sodium–glucose cotransporter inhibitors and kidney fibrosis: review of the current evidence and related mechanisms
Afşar, B., & Afşar, R. E. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00442-4 · Cited by 28
Luteolin improves nephropathy in hyperglycemic rats through anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms
Chen, L., Cheng, H. T., Liao, C.-K., Kuan, Y., Liang, T.-J., Tseng, T.-J., & Lin, H.-C. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105461 · Cited by 26
Lipin-1 deficiency deteriorates defect of fatty acid β-oxidation and lipid-related kidney damage in diabetic kidney disease
Lin, S., Wang, L., Jia, Y., Sun, Y., Qiao, P., Quan, Y., Liu, J., Hu, H., Yang, B., & Zhou, H. (2023) · Translational research · doi:10.1016/j.trsl.2023.07.004 · Cited by 25
Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis
Liang, I.-C., Chang, H.-H., Lai, Y.-J., Chan, C.-M., Sung, C.-H., Pu, C., Chang, D., Ho, C.-C., & Hung, C. (2025) · Medicina · doi:10.3390/medicina61020202 · Cited by 25
Renoprotective Effects of SGLT2 Inhibitors
Vallon, V. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.03.005 · Cited by 27
Self-citation
Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection
Haruhara, K., Kanzaki, G., & Tsuboi, N. (2022) · Hypertension Research · doi:10.1038/s41440-022-01061-5 · Cited by 28
Biology of the proximal tubule in body homeostasis and kidney disease
Hoenig, M. P., Brooks, C. R., Hoorn, E. J., & Hall, A. M. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae177 · Cited by 24
Factor XII signaling via uPAR-integrin β1 axis promotes tubular senescence in diabetic kidney disease
Elwakiel, A., Gupta, D., Rana, R., Manoharan, J., Al‐Dabet, M. M., Ambreen, S., Fatima, S., Zimmermann, S., Mathew, A., Li, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52214-8 · Cited by 27
O-GlcNAcylation Suppresses the Ion Current IClswell by Preventing the Binding of the Protein ICln to α-Integrin
Costa, R. R., Remigante, A., Civello, D. A., Bernardinelli, E., Szabó, Z., Morabito, R., Marino, A., Sarikas, A., Patsch, W., Paulmichl, M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607080 · Cited by 24
Hedgehog interacting protein activates sodium–glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes
Zhao, X. C., Chang, S., Pang, Y., Liao, M.-C., Peng, J., Ingelfinger, J. R., Chan, J. S. D., & Zhang, S. (2022) · Diabetologia · doi:10.1007/s00125-022-05810-6 · Cited by 24
Sex and Gender Related Differences in Diabetic Kidney Disease
Sridhar, V. S., Yau, K., Benham, J. L., Campbell, D. J. T., & Cherney, D. Z. I. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.04.007 · Cited by 23
Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease
Li, D., Hsu, F., Palmer, N. D., Liu, L., Choi, Y. A., Murea, M., Parks, J. S., Bowden, D. W., Freedman, B. I., & Ma, L. (2024) · Diabetes · doi:10.2337/db23-0540 · Cited by 28
SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2
Cai, X., Cao, H., Wang, M., Yu, P., Liang, X., Liang, H., Xu, F. L., & Cai, M. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05688-8 · Cited by 23
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use—Reviewing Protective Effects Exceeding Glycemic Control
Hanke, J., Romejko, K., & Niemczyk, S. (2025) · Molecules · doi:10.3390/molecules30204125 · Cited by 33
Role of the macula densa sodium glucose cotransporter type 1-neuronal nitric oxide synthase-tubuloglomerular feedback pathway in diabetic hyperfiltration
Zhang, J., Cai, J., Cui, Y., Jiang, S., Wei, J., Kim, Y. C., Chan, J. C. M., Thalakola, A., Le, T. T., Xu, L., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.037 · Cited by 23
Self-citation
Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models
Tauber, P., Sinha, F., Berger, R. S., Gronwald, W., Dettmer, K., Kühn, M., Trum, M., Maier, L. S., Wagner, S., & Schweda, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.761855 · Cited by 23
Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct
Sinha, F., Federlein, A., Biesold, A., Schwarzfischer, M., Krieger, K., Schweda, F., & Tauber, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1118358 · Cited by 23
Single-Nucleus Transcriptomic Analysis Reveals Important Cell Cross-Talk in Diabetic Kidney Disease
Wei, Y., Gao, X., Li, A., Liang, M., & Jiang, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.657956 · Cited by 22
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
Esposito, P. B., Picciotto, D., Cappadona, F., Costigliolo, F., Russo, E., Macciò, L., & Viazzi, F. C. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i10.1450 · Cited by 23
Anti-inflammatory potential of Empagliflozin
Pirklbauer, M. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00797-9 · Cited by 22
Klotho in kidney diseases: a crosstalk between the renin–angiotensin system and endoplasmic reticulum stress
Kale, A., Sankrityayan, H., Anders, H., & Gaikwad, A. B. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab340 · Cited by 21
3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy
Jung, J., Park, W. Y., Kim, Y. J., Kim, M. K., Choe, M., Jin, K., Seo, J. H., & Ha, E. (2022) · Antioxidants · doi:10.3390/antiox11020381 · Cited by 21
Renal Mechanisms of Diuretic Resistance in Congestive Heart Failure
Lameire, N. H. (2023) · Kidney and Dialysis · doi:10.3390/kidneydial3010005 · Cited by 21
Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
Das, S., & Ramanathan, G. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121414 · Cited by 21
Cardiorenal syndrome and diabetes: an evil pairing
Méndez, A. B., Vergara, A., Olivella, A., Azancot, M. A., Soriano-Colomé, T., & Soler, M. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1185707 · Cited by 21
The Molecular Mechanism of Renal Tubulointerstitial Inflammation Promoting Diabetic Nephropathy
Xue, R., Xiao, H., Kumar, V., Lan, X., Malhotra, A., Singhal, P. C., & Chen, J. (2023) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s436791 · Cited by 25
Assessment of nephron number and single-nephron glomerular filtration rate in a clinical setting
Tsuboi, N., Sasaki, T., Okabayashi, Y., Haruhara, K., Kanzaki, G., & Yokoo, T. (2021) · Hypertension Research · doi:10.1038/s41440-020-00612-y · Cited by 22
TRIM65 as a key regulator of ferroptosis and glycolysis in lactate-driven renal tubular injury and diabetic kidney disease
Yang, G., Liu, X., Li, Y.-C., Li, L., Xiang, J., Liang, Z., Jiang, M., & Yang, S. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116091 · Cited by 26
SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review
Kansara, A., Mubeen, F., & Shakil, J. (2022) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1120 · Cited by 22
Cell-Cycle Dysregulation in the Pathogenesis of Diabetic Kidney Disease: An Update
Deng, B., Song, A., & Zhang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032133 · Cited by 20
Fluid homeostasis induced by sodium-glucose cotransporter 2 inhibitors: novel insight for better cardio-renal outcomes in chronic kidney disease
Masuda, T., & Nagata, D. (2023) · Hypertension Research · doi:10.1038/s41440-023-01220-2 · Cited by 20
Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review
Das, S., Rajeswari, V. D., Venkatraman, G., Elumalai, R., Sivaraman, D., & Ramanathan, G. (2023) · Translational research · doi:10.1016/j.trsl.2023.11.002 · Cited by 22
An aldose reductase inhibitor, WJ-39, ameliorates renal tubular injury in diabetic nephropathy by activating PINK1/Parkin signaling
Yang, L., Xu, L., Hao, X., Song, Z., Zhang, X., Liu, P., Wang, S., He, Z., & Zou, L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176376 · Cited by 22
The safety outcomes of sodium-glucose cotransporter 2 inhibitors in patients with different renal function: A systematic review and meta-analysis
Bai, Y., Jin, J., Zhou, W., Zhang, S., & Xu, J. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.02.006 · Cited by 20
Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice
Okuma, H., Mori, K., Nakamura, S., Sekine, T., Ogawa, Y., & Tsuchiya, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147329 · Cited by 20
Recent advances of photoresponsive nanomaterials for diagnosis and treatment of acute kidney injury
Yao, S. J., Wang, Y., Mou, X., Yang, X., & Cai, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02906-6 · Cited by 21
Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease
Sharma, M., Singh, V., Sharma, R., Koul, A., McCarthy, E. T., Savin, V. J., Joshi, T., & Srivastava, T. (2022) · Biomedicines · doi:10.3390/biomedicines10020407 · Cited by 19
Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology
Sinha, S., & Haque, M. (2022) · Cureus · doi:10.7759/cureus.28944 · Cited by 19
Understanding the protective effects of SGLT2 inhibitors in type 2 diabetes patients with chronic kidney disease
Scheen, A. J., & Delanaye, P. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2014322 · Cited by 18
SIRT6’s function in controlling the metabolism of lipids and glucose in diabetic nephropathy
Wang, Y., Liu, T., Cai, Y., Liu, W., & Guo, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244705 · Cited by 19
SGLT2 inhibitor dapagliflozin protects the kidney in a murine model of Balkan nephropathy
Oe, Y., Kim, Y. C., Sidorenko, V. S., Zhang, H., Kanoo, S., Lopez, N., Goodluck, H. A., Crespo‐Masip, M., & Vallon, V. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00228.2023 · Cited by 18
Self-citation
YME1L-mediated mitophagy protects renal tubular cells against cellular senescence under diabetic conditions
Luo, Y., Zhang, L., Su, N., Liu, L., & Zhao, T. (2024) · Biological Research · doi:10.1186/s40659-024-00487-0 · Cited by 23
The Molecular Effects of Dietary Acid Load on Metabolic Disease (The Cellular PasaDoble: The Fast-Paced Dance of pH Regulation)
Williamson, M., Moustaïd‐Moussa, N., & Gollahon, L. (2021) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2021.777088 · Cited by 22
Inhibition of ferroptosis of renal tubular cells with total flavones of Abelmoschus manihot alleviates diabetic tubulopathy
Wang, M., Cai, Y., Fang, Q., Liu, Y., Wang, J., Chen, J., Fu, Y., Wan, B., Tu, Y., Wu, W., et al. (2022) · The Anatomical Record · doi:10.1002/ar.25123 · Cited by 17
Understanding ureteropelvic junction obstruction: how far have we come?
Costigan, C., & Rosenblum, N. D. (2023) · Frontiers in Urology · doi:10.3389/fruro.2023.1154740 · Cited by 17
Exploring the Cardiorenal Benefits of SGLT2i: A Comprehensive Review
Cersosimo, A., Drera, A., Adamo, M., Metra, M., & Vizzardi, E. (2024) · Kidney and Dialysis · doi:10.3390/kidneydial4040016 · Cited by 21
Recent advances in the management of secondary hypertension: chronic kidney disease
Masuda, T., & Nagata, D. (2020) · Hypertension Research · doi:10.1038/s41440-020-0491-4 · Cited by 17
CREDENCE: Significant Victory for Diabetic Kidney Disease
Verma, A., Patel, A. B., Upadhyay, A., & Waikar, S. S. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.04.002 · Cited by 16
Polymodal roles of TRPC3 channel in the kidney
Khayyat, N. H., Tomilin, V. N., Zaika, O., & Pochynyuk, O. M. (2020) · Channels · doi:10.1080/19336950.2020.1804153 · Cited by 16
Prognostic and Therapeutic Implications of Renal Insufficiency in Heart Failure
Jang, S. Y., & Yang, D. H. (2022) · International Journal of Heart Failure · doi:10.36628/ijhf.2021.0039 · Cited by 17
Genetic and Biological Effects of SLC12A3, a Sodium-Chloride Cotransporter, in Gitelman Syndrome and Diabetic Kidney Disease
Li, N., & Gu, H. F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.799224 · Cited by 15
Incretin and glucagon receptor polypharmacology in chronic kidney disease
McFarlin, B. E., Duffin, K. L., & Konkar, A. A. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2023 · Cited by 17
Current Concepts of Pediatric Acute Kidney Injury—Are We Ready to Translate Them into Everyday Practice?
Musiał, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143113 · Cited by 15
JMJD1A/NR4A1 Signaling Regulates the Procession of Renal Tubular Epithelial Interstitial Fibrosis Induced by AGEs in HK-2
Wang, S., Zuo, A., Jiang, W., Xie, J., Lin, H., Sun, W., Zhao, M., Xia, J., Shao, J., Zhao, X., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.807694 · Cited by 17
Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial
Hosseini, Z. S., Jamili, M. J., Ensan, B., Donyadideh, G., Shahri, B., Eshraghi, H., Darroudi, S., & Moohebati, M. (2025) · Scientific Reports · doi:10.1038/s41598-024-82991-7 · Cited by 14
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease
Ahluwalia, T. S., Rönkkö, T., Eickhoff, M. K., Curovic, V. R., Siwy, J., Eder, S., Denicolò, S., Mayer, G. J., Mischak, H., Rossing, P. R., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.11.020 · Cited by 15
The importance of proinflammatory failed-repair tubular epithelia as a predictor of diabetic kidney disease progression
Yagi-Tomita, A., Okuno-Ozeki, N., Uehara-Watanabe, N., Komaki, K., Umehara, M., Yamauchi-Sawada, H., Minamida, A., Sunahara, Y., Matoba, Y., Nakamura, I., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109020 · Cited by 14
PPARα/δ dual agonist H11 alleviates diabetic kidney injury by improving the metabolic disorders of tubular epithelial cells
Ke, Q., Xiao, Y., Liu, D., Shi, C., Shen, R., Qin, S., Jiang, L., Yang, J., & Zhou, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116076 · Cited by 15
Iridoids modulate inflammation in diabetic kidney disease: A review
Zhou, T., Tian, N., Li, L., & Yu, R. (2024) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2024.03.010 · Cited by 14
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?
Moreno, Ó., Reyes‐García, R., Pardo, I. M., López-Martínez, M., & Soler, M. J. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae039 · Cited by 15
Imaging and spatially resolved mass spectrometry applications in nephrology
Gorman, B. L., Shafer, C. C., Ragi, N., Sharma, K., Neumann, E. K., & Anderton, C. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00946-1 · Cited by 19
Effect of a sodium restriction diet on albuminuria and blood pressure in diabetic kidney disease patients: a meta-analysis
Chen, Y., Wang, X., Jia, Y., Zou, M., Zhen, Z., & Xue, Y. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-03035-x · Cited by 15
Caffeic acid phenethyl ester protects renal tubular epithelial cells against ferroptosis in diabetic kidney disease via restoring PINK1-mediated mitophagy
Lu, Y., Zhu, Y., Feng, S., Cong, Q., Chen, S., Zeng, Y., Song, K., & Hu, J. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01318-y · Cited by 13
Engineering DNA tetrahedron as a sensing surface of lateral flow test strips and ratiometric visual detection of exosomal microRNA-150–5p
Yongjie, X., Da, J., Lan, Q., Luo, J., Lu, Z., Peng, R., Yu, F., & Zha, Y. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134266 · Cited by 13
Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?
Çöpür, S., Yıldız, A. B., Basile, C., Tuttle, K. R., & Kanbay, M. (2022) · Journal of Nephrology · doi:10.1007/s40620-022-01422-w · Cited by 15
Roles of extracellular vesicles in ageing-related chronic kidney disease: Demon or angel
Yin, S., Zhou, Z., Fu, P., Jin, C., Wu, P., Ji, C., Shan, Y., Shi, L., Xu, M., & Qian, H. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106795 · Cited by 12
Targeted deletion of von-Hippel-Lindau in the proximal tubule conditions the kidney against early diabetic kidney disease
Kunke, M., Knöfler, H., Dahlke, E., Rodriguez, L. Z., Böttner, M., Larionov, A. A., Saudenova, M., Ohrenschall, G. M., Westermann, M., Porubský, Š., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06074-7 · Cited by 12
RXRα/MR signaling promotes diabetic kidney disease by facilitating renal tubular epithelial cells senescence and metabolic reprogramming
Feng, Q., Su, C., Yang, C., Wu, M., Li, X., Lin, X., Zeng, Y., He, J., Wang, Y., Guo, L., et al. (2024) · Translational research · doi:10.1016/j.trsl.2024.10.001 · Cited by 12
Human Umbilical Cord Mesenchymal Stem Cells Alleviate Diabetic Nephropathy by Inhibiting Ferroptosis via the JNK/KEAP1/NRF2 Signaling Pathway
Zhu, Y., Dong, C., Xu, Z., Lou, Y., Tian, N., Guan, Y., Nie, P., Luo, M., & Luo, P. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0575 · Cited by 12
Canagliflozin inhibits hedgehog interacting protein (Hhip) induction of tubulopathy in diabetic Akita mice
Chang, S., Liao, M.-C., Miyata, K. N., Pang, Y., Zhao, X. C., Peng, J., Rivard, A., Ingelfinger, J. R., Chan, J. S. D., & Zhang, S. (2025) · Translational research · doi:10.1016/j.trsl.2024.12.005 · Cited by 12
Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress
Mu, L., Chen, N., Chen, Y., Yang, Z., Zhou, H., Song, S., & Shi, Y. (2022) · International Journal of Endocrinology · doi:10.1155/2022/6073911 · Cited by 12
The Benefit of Sodium-Glucose Co-Transporter Inhibition in Heart Failure: The Role of the Kidney
Gronda, E., Vanoli, E., Iacoviello, M., Caldarola, P., Gabrielli, D., & Tavazzi, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911987 · Cited by 12
Single-cell transcriptomics: A new tool for studying diabetic kidney disease
Mao, Z., Gao, Z., Liu, Y., Liu, D., Liu, Z., & Wu, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2022.1053850 · Cited by 15
CCN2 Binds to Tubular Epithelial Cells in the Kidney
Rayego‐Mateos, S., Morgado‐Pascual, J. L., Lavoz, C., Rodrigues-Díez, R. R., Márquez‐Expósito, L., Tejera‐Muñoz, A., Tejedor-Santamaria, L., Rubio-Soto, I., Marchant, V. A., & Ruiz‐Ortega, M. (2022) · Biomolecules · doi:10.3390/biom12020252 · Cited by 12
ACSF2-PGK1 interaction promotes ferroptosis in renal tubular epithelial cells of diabetic nephropathy by regulating Keap1/Nrf2 signaling
Liu, X., Chen, C., Zhu, S., Luo, X., Gao, L., Hu, Z., Ma, Y., Jiang, L., & Wu, Y. (2025) · Redox Report · doi:10.1080/13510002.2025.2529618 · Cited by 13
Factors that influence the Na/K-ATPase signaling and function
Gao, Y., Xu, Y., Bai, F., Puri, R., Tian, J., & Liu, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1639859 · Cited by 11
XIAP-ULK1-mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease
Hu, H., Ji, R., Hao, Y., Liu, Z., Yang, J., Cao, Y., & Yang, Q. (2025) · Autophagy · doi:10.1080/15548627.2025.2581214 · Cited by 13
Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis
Chuang, M., Tang, Y., Chen, J., Pan, H., Liao, H., Chu, W.-K., Cheng, C., Wu, V., & Heung, M. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0201 · Cited by 14
Targeting SIRT2 in Aging-Associated Fibrosis Pathophysiology
Huang, Y., He, W. G., Zhang, Y., Zou, Z., Han, L., Luo, J., Wang, Y., Tang, X., Li, Y., Bao, Y., et al. (2024) · Aging and Disease · doi:10.14336/ad.202.0513 · Cited by 11
Acetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1
Ginsberg, C., Seegmiller, J. C., Vallon, V., Jin, S. S., Thomas, R. L., BOEDER, S. C., Pettus, J., & Ix, J. H. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000515 · Cited by 11
Self-citation
Dihydrolipoamide S-acetyltransferase activation alleviates diabetic kidney disease via AMPK-autophagy axis and mitochondrial protection
Zhou, P., Wang, N., Lu, S., Xiong, J., Zhang, Y., Jiang, Q., Qian, Q., Zhou, Q., Liu, J., & Chen, S. (2024) · Translational research · doi:10.1016/j.trsl.2024.09.005 · Cited by 11
An integrated bioinformatics analysis and experimental study identified key biomarkers CD300A or CXCL1, pathways and immune infiltration in diabetic nephropathy mice
LIANG, W., Luo, Q., ZHANG, Z., YANG, K., YANG, A., Chi, Q., & HU, H. (2022) · Biocell · doi:10.32604/biocell.2022.019300 · Cited by 11
The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification
Niu, H., Fan, L., Zhao, L., Yao, R., He, X., Lu, B., & Pang, Z. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115283 · Cited by 11
Influence of carnosine and carnosinase-1 on diabetes-induced afferent arteriole vasodilation: implications for glomerular hemodynamics
Rodriguez-Niño, A., Pastene, D. O., Hettler, S. A., Qiu, J., Albrecht, T., Vajpayee, S., Perciaccante, R., Gretz, N., Bakker, S. J. L., Krämer, B. K., et al. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00232.2021 · Cited by 11
The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children—A Single Center Experience
Musiał, K., Kałwak, K., & Zwołińska, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051113 · Cited by 11
The evolution and future of diabetic kidney disease research: a bibliometric analysis
Wei, Y., & Jiang, Z. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02369-z · Cited by 11
Knockout of Macula Densa Neuronal Nitric Oxide Synthase Increases Blood Pressure in db/db Mice
Zhang, J., Wang, X., Cui, Y., Jiang, S., Wei, J., Chan, J., Thalakola, A., Le, T., Xu, L., Zhao, L., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17643 · Cited by 11
Self-citation
Activation of MST1 protects filtration barrier integrity of diabetic kidney disease in mice through restoring the tight junctions of glomerular endothelial cells
Yang, T., Liu, Y., Shao, Y.-T., Li, L., Pan, D.-D., Wang, T., Jiang, Z., Li, B.-J., Qian, S., Yan, M., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01421-6 · Cited by 10
Protein UHRF1-mediated dual dysregulation of molecular chaperone GRP78 induces endoplasmic reticulum stress and aggravates diabetic nephropathy
Yang, R., Hou, Q., Chen, R., Ma, Z., Jiang, S., & Liu, Z. (2025) · Kidney International · doi:10.1016/j.kint.2025.07.023 · Cited by 14

Authors: Vallon, V., & Thomson, S. C.
Affiliations: University of California San Diego (US)
Corresponding author: Vallon, Volker
ORCID: Vallon, Volker
Thomson, Scott C.
Venue: Nature Reviews Nephrology
Publisher: Springer Science and Business Media LLC
Published: 2020-03-09
Volume: 16
Issue: 6
Pages: 317-336
ISSN: 1745-8323 (ISSN-L)
1759-5061
1759-507X
DOI: 10.1038/s41581-020-0256-y
PMC: PMC7242158
OpenAlex: W3009930262
Cited by: 465
References: 211
Citations by year: 2026: 80 · 2025: 75 · 2024: 79 · 2023: 70 · 2022: 79 · 2021: 55 · 2020: 24
FWCI: 9.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Reviews Nephrology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institutes of Health (1rf1ag061296-01a1)
National Institute on Aging (RF1-AG061296)
National Heart, Lung, and Blood Institute (R01HL142814)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK079337, R01DK106102, R01DK112042)
Topics: Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: diabetic nephropathy, glomerular hyperfiltration, tubuloglomerular feedback, SGLT2, SGLT1, proximal tubular reabsorption, macula densa, nitric oxide, renal fibrosis, SGLT2 inhibitors, glomerular filtration rate
MeSH terms: Sodium-Glucose Transporter 2 Inhibitors, Chlorides, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Fibrosis, Glomerular Filtration Rate, Glucose, Humans, Hypertrophy, Inflammation, Kidney Glomerulus, Kidney Tubules, Nephrons, Nitric Oxide, Sodium, Cellular Senescence, Sodium-Glucose Transporter 1, Sodium-Glucose Transporter 2, Glomerular Filtration Barrier, Renal Reabsorption

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The tubular hypothesis of nephron filtration and diabetic kidney disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks